[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Younossi et al., 2014 - Google Patents

The impact of hepatitis C burden: an evidence‐based approach

Younossi et al., 2014

View PDF
Document ID
11647159381584323144
Author
Younossi Z
Kanwal F
Saab S
Brown K
El‐Serag H
Kim W
Ahmed A
Kugelmas M
Gordon S
Publication year
Publication venue
Alimentary pharmacology & therapeutics

External Links

Snippet

Background Infection with the hepatitis C virus (HCV) has been considered a major cause of mortality, morbidity and resource utilisation in the US. In addition, HCV is the main cause of hepatocellular cancer (HCC) in the US. Recent developments in the diagnosis and …
Continue reading at www.chronicliverdisease.org (PDF) (other versions)

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/345Medical expert systems, neural networks or other automated diagnosis
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/576Immunoassay; Biospecific binding assay for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Younossi et al. The impact of hepatitis C burden: an evidence‐based approach
Bartlett et al. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: impact of direct acting antivirals
Stepanova et al. Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity
Deleuran et al. Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based study
Armstrong et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Eslam et al. Meta‐analysis: insulin resistance and sustained virological response in hepatitis C
Younossi et al. Associations of chronic hepatitis C with metabolic and cardiac outcomes
Singal et al. Alcohol‐associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics
Fabrizi et al. Post‐transplant diabetes mellitus and HCV seropositive status after renal transplantation: meta‐analysis of clinical studies
Teschke et al. Drug-induced liver injury: Is chronic liver disease a risk factor and a clinical issue?
Fu et al. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with new onset diabetes: a nationwide cohort study
Chen et al. Meta‐analysis: IL 28 B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon‐α and ribavirin
Gordon et al. Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study
Rangnekar et al. Meta‐analysis: IL‐28 B genotype and sustained viral clearance in HCV genotype 1 patients
Rutter et al. Successful anti‐viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C
Brown et al. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs
Vagu et al. Serum iron markers in patients with chronic hepatitis C infection
Ko et al. Diabetes, hepatitis virus infection and hepatocellular carcinoma: a case–control study in hepatitis endemic area
Kallman et al. Screening for hepatitis B, C and non‐alcoholic fatty liver disease: a survey of community‐based physicians
Van Der Meer et al. Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters
Huang et al. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort study
Trimble et al. Mortality associated with alcohol‐related liver disease
Kim et al. Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Younossi et al. Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C
Huang et al. Diabetes, hepatocellular carcinoma, and mortality in hepatitis C‐infected patients: a population‐based cohort study